An exploratory open label phase 1b study of secukinumab in patients with moderate to severe papulopustular rosacea Kumar, A., Chiou, A., Shih, Y., Li, S., Chang, A. ELSEVIER SCIENCE INC. 2019: B15

View details for DOI 10.1016/j.jid.2019.06.071

View details for Web of Science ID 000482187300093